AMGN
Price
$447.28
Change
+$8.94 (+2.04%)
Updated
Oct 22 closing price
Capitalization
241.81B
12 days until earnings call
Intraday BUY SELL Signals
MIRA
Price
$0.62
Change
-$0.06 (-8.82%)
Updated
Oct 22 closing price
Capitalization
26.22M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMGN vs MIRA

AMGN vs MIRA Comparison Chart in %
View a ticker or compare two or three
VS
AMGN vs. MIRA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and MIRA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMGN with price predictions
Oct 22, 2026

AMGN in upward trend: 10-day moving average broke above 50-day moving average on October 16, 2026

The 10-day moving average for AMGN crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on AMGN as a result. In 47 of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on September 24, 2026. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in 27 of 47 cases over the following month. The odds of a continued upward trend are 57%.

AMGN moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in 189 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 151 of 272 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.

AMGN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 15 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.689) is normal, around the industry mean (-3.019). P/E Ratio (27.576) is within average values for comparable stocks, (21.251). Projected Growth (PEG Ratio) (2.524) is also within normal values, averaging (5.738). Dividend Yield (0.023) settles around the average of (0.041) among similar stocks. P/S Ratio (5.371) is also within normal values, averaging (4.033).

A.I.Advisor
a Summary for MIRA with price predictions
Oct 22, 2026

MIRA in +6.18% Uptrend, growing for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MIRA advanced for three days, in 103 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRA as a result. In 53 of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for MIRA turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In 25 of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

MIRA moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIRA crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

MIRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MIRA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.213) is normal, around the industry mean (-3.019). P/E Ratio (-0.511) is within average values for comparable stocks, (21.251). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. MIRA's P/S Ratio (0.000) is slightly lower than the industry average of (4.033).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. MIRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMGN: Fundamental Ratings
AMGN
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
5
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
7
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMGNMIRA
RSI
ODDS (%)
Bearish Trend 1 day ago
54%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AMGN: $447.28 vs. MIRA: $0.68)
Brand notoriety: AMGN: Notable vs. MIRA: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 106% vs. MIRA: 13%
Market capitalization -- AMGN: $241.81B vs. MIRA: $26.22M
AMGN [@Pharmaceuticals: Major] is valued at $241.81B. MIRA’s [@Pharmaceuticals: Major] market capitalization is $26.22M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.13T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $206.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 4 FA rating(s) are green while MIRA’s FA Score has 1 green FA rating(s).

  • AMGN’s FA Score: 4 green, 1 red.
  • MIRA’s FA Score: 1 green, 4 red.
According to our system of comparison, AMGN is a better buy in the long-term than MIRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 6 TA indicator(s) are bullish while MIRA’s TA Score has 2 bullish TA indicator(s).

  • AMGN’s TA Score: 6 bullish, 4 bearish.
  • MIRA’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than MIRA.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +3.05% price change this week, while MIRA (@Pharmaceuticals: Major) price change was -0.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.32%. For the same industry, the average monthly price growth was -5.34%, and the average quarterly price growth was +5.08%.

Reported Earning Dates

AMGN is expected to report earnings on Nov 03, 2026.

MIRA is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.32% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
MIRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-8.48%
AMRN - MIRA
20%
Poorly correlated
+0.78%
GRFS - MIRA
17%
Poorly correlated
-0.67%
SNY - MIRA
15%
Poorly correlated
+2.42%
BIIB - MIRA
11%
Poorly correlated
+5.34%
AMGN - MIRA
10%
Poorly correlated
+2.04%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEO96.693.84
+4.14%
Diageo plc
IMPP4.90-0.05
-1.01%
Imperial Petroleum
ROAD83.93-1.01
-1.19%
Construction Partners
OPTH3.28-0.12
-3.53%
Optimi Health Corp
EE31.52-1.50
-4.54%
Excelerate Energy